Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06583863
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-02
Brief Title:
Parasitic Infections and Ulcerative Colitis Combining Anti-parasitic and Immunomodulatory Treatments May Achieve Remission
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Parasitic Infection Flares up the Activity of Ulcerative Colitis However Combined Immunomodulatory Therapy With Anti-parasitic Treatment Could Proceed Toward Remission
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study aimed to explore the link between parasitic infections and the severity of ulcerative colitis UC 120 UC patients were divided into three groups those without infection those with Giardia lamblia infection treated with metronidazole and those with Giardia infection treated with a combination of metronidazole and E purpurea The results revealed that patients with Giardia infections exhibited more severe UC symptoms All groups experienced improved symptoms following treatment but the combination therapy group demonstrated the most significant improvement Remission rates were highest in the group without infection and the group receiving combination therapy Additionally the study identified E purpurea therapy and a substantial reduction in SCCAI score as significant predictors of higher remission rates
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None